Samuel Lafayette Murphy

Insider Reports History

Entity
Individual
Location
C/O Viracta Therapeutics, Inc., 2533 South Coast Hwy., Ste. 210, Cardiff, CA
Signature
/s/ Michael E. Faerm, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Lafayette Murphy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viracta Therapeutics, Inc. Director Stock Option (Right to Buy) 50K Jun 20, 2024 Direct

Insider Reports Filed by Samuel Lafayette Murphy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIRX Viracta Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
VIRX Viracta Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
VIRX Viracta Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director